Tenax Therapeutics
Stock Forecast, Prediction & Price Target
Tenax Therapeutics Financial Estimates
Tenax Therapeutics Revenue Estimates
Tenax Therapeutics EBITDA Estimates
Tenax Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $2M Low: $2M High: $2M avg. 0% | Avg: $4.15M Low: $4.15M High: $4.15M avg. 107.82% | Avg: $140.37M Low: $140.37M High: $140.37M avg. 3277.16% | Avg: $250.59M Low: $250.59M High: $250.59M avg. 78.52% |
Net Income
% change YoY
| $-32.73M N/A | $-11.04M 66.26% | $-7.71M 30.17% | Avg: $-18.80M Low: $-1.36M High: $-481.98K avg. -143.85% | Avg: $-16.64M Low: $-1.06M High: $-337.88K avg. 11.46% | Avg: $3.73M Low: $3.73M High: $3.73M avg. 122.46% | Avg: $5.55M Low: $5.55M High: $5.55M avg. 48.50% |
EBITDA
% change YoY
| $-32.36M N/A | $-10.93M 66.22% | $-8.22M 24.73% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$2,545.11 N/A | -$600.46 76.40% | -$31.09 94.82% | Avg: -$3.72 Low: -$5.49 High: -$1.94 avg. 88.05% | Avg: -$2.83 Low: -$4.29 High: -$1.36 avg. 23.95% | Avg: $15.05 Low: $15.05 High: $15.05 avg. 632.74% | Avg: $22.35 Low: $22.35 High: $22.35 avg. 48.50% |
Operating Expenses
% change YoY
| $32.72M N/A | $11.05M -66.22% | $8.23M -25.50% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Tenax Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 9.64% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -1.36M, average is -18.80M and high is -481.98K.
What is Tenax Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 865.87% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $2M, average is $2M and high is $2M.
What is Tenax Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 198.31% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$5.49, average is -$3.72 and high is $-1.94.